Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma

Abstract Introduction Splenic marginal zone lymphoma (SMZL) is a rare low-malignant Non-Hodgkin lymphoma (NHL), in which immune mediated paraneoplastic phenomena such as autoimmune hemolytic anemia (AIHA), autoimmune thrombocytopenia (ITP) and C1 esterase inhibitor deficiency are relatively common....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Thrombosis research 2014-11, Vol.134 (5), p.980-984
Hauptverfasser:	Gebhart, J, Lechner, K, Skrabs, C, Sliwa, T, Müldür, E, Ludwig, H, Nösslinger, T, Vanura, K, Stamatopoulos, K, Simonitsch-Klupp, I, Chott, A, Quehenberger, P, Mitterbauer-Hohendanner, G, Pabinger, I, Jäger, U, Geissler, K
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antibodies, Monoclonal, Murine-Derived - therapeutic use Antineoplastic Agents - therapeutic use Antiphospholipid antibodies Female Hematology, Oncology and Palliative Medicine Humans Immunotherapy Lupus anticoagulant Lupus Coagulation Inhibitor - analysis Lymphoma, B-Cell, Marginal Zone - complications Lymphoma, B-Cell, Marginal Zone - pathology Lymphoma, B-Cell, Marginal Zone - therapy Male Middle Aged Retrospective Studies Rituximab SMZL Spleen - pathology Splenectomy Splenic marginal zone lymphoma Splenic Neoplasms - complications Splenic Neoplasms - pathology Splenic Neoplasms - therapy Thrombosis Thrombosis - complications Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!